Norton Rose Fulbright has hired a senior competition partner from Covington & Burling for its Brussels antitrust team. The appointment of Miranda Cole will bolster the breadth and depth of the firm’s global antitrust and competition team.
Miranda Cole brings with her a broad competition practice that is particularly focused on the tech and life sciences sectors. Her experience spans advising clients on strategic mandates around merger control, abuse of dominance, anticompetitive agreements and other compliance work. She also advises clients on emerging regulatory frameworks in the tech and life sciences areas.
Identified asa ‘notable practitioner’ by the legal directory Chambers and Partners, she is joining NRF fresh from being part of the Covington team that advised Brussels-based biopharmaceutical giant UCB on competition aspects of its $1.9bn acquisition of US outfit Zogenix, maker of potential ‘blockbuster’ epilepsy drug Fintepla, which completed last month.
Ian Giles, head of antitrust and competition at Norton Rose Fulbright for Europe, Middle and Asia, said: “Miranda has extremely impressive experience, particularly across technology and life sciences, and has worked with many of the top companies in these sectors.
This hire demonstrates our ongoing commitment to maintaining a top tier antitrust team, and building our Brussels capabilities at the heart of the EU in this time of significant regulatory change.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI